It turns out we might be building up our brain when we exercise.” Betley is corresponding author of the researchers’ published paper in Neuron, titled “ Exercise-induced activation of ventromedial ...

Studies reveal the therapeutic mechanism of action for levetiracetam to prevent the production of Aβ and, consequently, downstream irreversible damage.

Accent Therapeutics launched a Phase I/II clinical trial last year to begin testing a small molecule inhibitor of KIF18A in ovarian cancers.

Products released at this year's meeting covered a broad range of applications from sustainable labware to protein assays to instruments.

Unchained Labs launched Stuntman during the SLAS meeting in Boston: an automation platform that combines native, natural-language AI with flexible hardware.

Michelle Lee, PhD, unpacks how physical AI that integrate scientific reasoning with the wet lab will accelerate biological discovery.

This eBook explores how innovation and shifting patient expectations are reshaping modern diagnostics—and advancing progress toward global STI elimination goals.

AI can help protein engineers optimize the transcription enzymes used to make mRNA-based vaccines and therapeutics, say the authors of a new study.

Designing a high-density fed-batch, E. coli-based strategy to produce recombinant GLP-1 cuts upstream production costs 20–30%.

Ion mobility adds a powerful new dimension to biopharma separations as complex therapeutics outgrow traditional LC–MS.

Biologists have engineered adeno-associated viruses that are better at capsid filling, potentially resulting in higher productivity.

The company, based in Norcross, GA, manufactures more than 900 DNA and RNA isolation products used in clinical research, biotechnology, genomics, and agriculture.